pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • SODIUM ACETATE ANHYDROUS
    SODIUM ACETATE ANHYDROUS
    no indication SOMERSET THERAPS LLC
  • SODIUM CHLORIDE
    SODIUM CHLORIDE
    no indication LIEBEL-FLARSHEIM
  • SODIUM FLUORIDE F 18
    SODIUM FLUORIDE F 18 (SODIUM FLUORIDE F-18)
    no indication 3D IMAGING DRUG
  • SODIUM FLUORIDE F18
    SODIUM FLUORIDE F18
    no indication CARDINAL HEALTH 414
← prev
page 134 of 231
next →
131
Pain89
Neurology1
  • SODIUM IODIDE I 123
    SODIUM IODIDE I 123
    no indication CURIUM
  • SODIUM PHENYLACETATE AND SODIUM BENZOATE
    SODIUM PHENYLACETATE AND SODIUM BENZOATE
    no indication Navinta LLC
  • SODIUM SULFACETAMIDE
    SODIUM SULFACETAMIDE
    no indication BAUSCH
  • SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL
    SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL
    no indication STRIDES PHARMA INTL
  • SODIUM SULFATE, POTASSIUM SULFATE, AND MAGNESIUM SULFATE
    SODIUM SULFATE, POTASSIUM SULFATE, AND MAGNESIUM SULFATE
    no indication BIONPHARMA
  • Phase 1
    SON-1010
    Head And Neck Cancer Sonnet BioTherapeutics Holdings Inc
  • SORAFENIB
    SORAFENIB
    no indication TORRENT
  • SORBITOL-MANNITOL
    SORBITOL-MANNITOL (SORBITOL AND MANNITOL)
    no indication OTSUKA ICU MEDCL
  • Phase 1
    SORC-13
    Adenoid Cystic Carcinoma (ACC) Soricimed Biopharma Inc
  • Phase 1
    SOT-201
    Solid Tumor SOTIO Biotech AS
  • Phase 3
    SP-0218
    Yellow Fever$SNY Sanofi
  • Phase 2
    SP-0230
    Neisseria meningitidis Infections$SNY Sanofi
  • Phase 2
    SP-0256
    Human Metapneumovirus Infections$SNY Sanofi
  • Phase 2
    SP-0269
    Chlamydia trachomatis Infections$SNY Sanofi
  • Phase 2
    SP-101
    Cystic Fibrosis Spirovant Sciences Inc
  • Preclinical
    SPC-14
    Alzheimer's Disease$SILO Silo Pharma, Inc.
  • Preclinical
    SPC-15
    Anxiety Disorders$SILO Silo Pharma, Inc.
  • Phase 2
    SPG-601
    Fragile X Syndrome Spinogenix Inc
  • Preclinical
    SPID-961
    Childhood Epilepsy Shackelford Pharma Inc
  • Preclinical
    SPL-23
    Cystic Fibrosis SpliSense Ltd
  • Phase 2
    SPL-84
    Cystic Fibrosis SpliSense Ltd
  • Phase 2
    SPN-821
    Major Depressive Disorder$SUPN SUPERNUS PHARMACEUTICALS, INC.
  • Preclinical
    SPU-16
    Multiple Sclerosis$SILO Silo Pharma, Inc.
  • Phase 2
    SPVN-06
    Retinitis Pigmentosa (Retinitis) SparingVision SAS
  • Phase 1
    SPX-303
    Solid Tumor$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-306
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.